Please assess the completion status of the following clinical trial:

Trial Title: Combination Chemotherapy Followed by Surgery in Treating Patients With Stomach Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: None
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
DISEASE CHARACTERISTICS:~* Histologically proven, previously untreated gastric cancer~  * Stage IB, II, III, or IV (T3-4, N0 OR any T, N1-2, M0)~ * No metastases~PATIENT CHARACTERISTICS:~Age:~* 18 and over~Performance status:~* SWOG 0-2~Life expectancy:~* Not specified~Hematopoietic:~* WBC at least 4000/mm\^3~* Platelet count at least 100,000/mm\^3~* Hemoglobin at least 9 g/dL~Hepatic:~* Bilirubin less than 2 mg/dL~* SGOT/SGPT no greater than 2 times upper limit of normal (ULN)~* Alkaline phosphatase no greater than 3 times ULN~* PT, aPTT, and TT normal~* No Gilbert's disease~Renal:~* BUN no greater than 30 mg/dL~* Creatinine no greater than 1.5 mg/dL OR~* Creatinine clearance greater than 60 mL/min~Cardiovascular:~* No myocardial infarction within the past 3 months~* No congestive heart failure requiring therapy~Other:~* No other invasive malignancy in the past 5 years except adequately treated basal or squamous cell skin cancer or carcinoma in situ of the cervix~* No active or uncontrolled infection~* HIV negative~* No other severe concurrent disease~* No psychiatric disorders that would preclude compliance~* Not pregnant or nursing~* Negative pregnancy test~* Fertile patients must use effective contraception~PRIOR CONCURRENT THERAPY:~Biologic therapy:~* Not specified~Chemotherapy:~* No prior chemotherapy for gastric cancer~Endocrine therapy:~* Not specified~Radiotherapy:~* No prior radiotherapy for gastric cancer~Surgery:~* No prior surgery for gastric cancer~* No emergent need for surgery for gastrointestinal obstruction, perforation, or hemorrhage

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).